Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Bayh-Dole Act (1)
- Corporations (1)
- DNA sequences (1)
- Decision-making (1)
- Decisions (1)
-
- Experts (1)
- Federal agencies (1)
- Funding (1)
- Human Genome Project (1)
- National Institutes of Health (1)
- Opinion (1)
- Patent applications (1)
- Patent law (1)
- Public domain (1)
- Public policy (1)
- Research and development (1)
- Risk (1)
- Scientific research (1)
- Sponsored research (1)
- Statistics (1)
- Technology transfers (1)
Articles 1 - 2 of 2
Full-Text Articles in Law
Roundtable Discussion: Science, Environment, And The Law, James E. Krier
Roundtable Discussion: Science, Environment, And The Law, James E. Krier
Articles
Science, environment, and the law is our topic. The problem of interest to me has to do with risk regulation and, more particularly, with the fact that technical and scientific views of risk differ dramatically from lay or public views. How is this conflict to be managed and resolved? I have to go through my account very quickly, given the time constraint, so let me mention that it is based on an article that sets out my arguments at length.'
A Technology Policy Perspective On The Nih Gene Patenting Controversy, Rebecca S. Eisenberg
A Technology Policy Perspective On The Nih Gene Patenting Controversy, Rebecca S. Eisenberg
Articles
This article will use the NIH patent controversy as a focal point for considering when the results of government-sponsored research should be patented and when they should be dedicated to the public domain. First, this article will review the recent history of federal government policy on patenting the results of government-sponsored research. Next, this article will highlight some of the complexities involved in achieving technology transfer from the public sector to the private sector that current policy may oversimplify. With this background, this article will return to a more detailed analysis of the NIH cDNA patenting controversy and consider the …